Health Equity & SDoH Implementation Congress| 2024 | Atlanta

Ensuring financial efficiency on health equity strategies to create a data driven and equitable healthcare system

DOWNLOAD THE AGENDA

Health Equity & SDoH Implementation Congress | 2024 | Atlanta

ATLANTA

8-9 May, 2024

We celebrate the progression of health equity action from all voices involved in creating better outcomes for under-served patients.

WHY ATTEND?

Save yourself the $93 billion lost annually in excess medical costs from racial and ethnic health disparities whilst creating a higher quality and more equitable health systems at the Health Equity & SDoH Implementation Congress

Join us in Atlanta to ensure strong financial returns on your health equity and SDoH initiatives by hearing case studies from leading payers who have successfully seen return on investment from their initiatives.

Create data driven, evidence based and targeted approaches by discovering how you can increase your data collection and improve data sharing across the industry through z codes, pay-vider models and new technologies.

PAYERS ATTEND FOR FREE

Ensure strong financial returns from your health equity and SDoH initiatives with evidence from real-world case studies insights from leading payers, who have championed health equity and witnessed tangible returns on their investments.
Streamline the implementation of health equity and SDoH strategies in your business by connecting with decision makers from across the entire health equity ecosystem with our networking platform allow you to pre-book 1-2-1 meetings.
Discover the power of data-driven, evidence-based strategies by exploring innovative approaches to increase data collection and enhance data sharing across the industry.

2

Main Event Days

150+

Industry Experts

20+

Industry Leading Speakers

10+

Dedicated Networking Hours

Register Now
Join us and 350+ other health equity leaders in Atlanta this May! If you are from a healthcare plan or provider organization, you can register to join us at the event for free.
REGISTER YOUR FREE PLACE
View the 2024 Agenda
Find out who's speaking in 2024, take a look at our new interactive sessions and start planning your event schedule!
VIEW HERE
See Full Partnership Prospectus
Learn about the full range of partnership opportunities available on our 2024 partnership prospectus
VIEW HERE

Connect with senior leaders from across the health care industry including

FEATURED: EXCLUSIVE INTERVIEW WITH TAMIRA M. MOON

We recently caught up with industry trailblazer and speaker Tamira M. Moon, Director of Health Equity & Diversity Initiatives, Association of State & Territorial Health Officials.

Tamira recently founded the To the Moon & Back Foundation (TTMAB) that leverages its strong community connections to enact programs that reshape the landscape of social determinants impacting health. TTMAB is already seeing benefits in healthcare access and screening for underrepresented communities through its health education program.

Read the full interview here!

VIEW FULL INTERVIEW

OUR COMMUNITY OF PAYERS AND PROVIDERS

HEALTH EQUITY SERIES SPEAKERS

Timshel Tarbet

Director Innovation Health Equity Accelerator

Providence Health Plan

Shannon Wilson

Vice President Population Health & Health Equity

Priority Health

Abdou Bah

Senior Vice President, Medical Management & Chief Health Equity Officer

Emblem Health

Lonie Haynes

SVP Chief Diversity, Health Equity, Inclusion and Justice Officer

Rochester Regional Health

Shiela Phicil

Director Innovation Health Equity Accelerator

Boston Medical Center

Tamira M. Moon

Director Health Equity and Diversity Initiatives, Association of State and Territorial Health Officials, CEO and Founder

To the Moon & Back Foundation, Inc.

INDUSTRY LEADING SPEAKERS INCLUDE

Timshel Tarbet

Director Innovation Health Equity Accelerator

Providence Health Plan

Shannon Wilson

Vice President Population Health & Health Equity

Priority Health

Abdou Bah

Senior Vice President, Medical Management & Chief Health Equity Officer

Emblem Health

Lonie Haynes

SVP Chief Diversity, Health Equity, Inclusion and Justice Officer

Rochester Regional Health

Shiela Phicil

Director Innovation Health Equity Accelerator

Boston Medical Center

Tamira M. Moon

Director Health Equity and Diversity Initiatives, Association of State and Territorial Health Officials, CEO and Founder

To the Moon & Back Foundation, Inc.

Stephen Framil

Corporate Global Head of Accessibility

Merck

Lisa Porter

Director of Community Engagement Health Equity & Social Impact

Humana

Dr Bryan Buckley

Director, Health Equity Initiatives

National Committee for Quality Assurance - NCQA

Robyn Bussey

Director, Just Health

Partnership for Southern Equity

Michael Bagel

Associate Vice President, Public Policy

Alliance of Community Health Plans

Roslyn Moore

Deputy Director for Programs

Office of Minority Health

Reshunda Redmond

Sr. Director, Quality and Safety Oversight

Kaiser Permanente Georgia

Belkis Pimentel

Physician Director of Quality Performance and Population Health

Kaiser Permanente

SESSION HIGHLIGHTS INCLUDE:

Filter by:

All Topics

All Job Focuses

Identifying and overcoming the Barriers to Implementing Health Equity and Social Determinants of Health

Author:

Shiela Phicil

Director Innovation Health Equity Accelerator

Boston Medical Center

Author:

Dr Bryan Buckley

Director, Health Equity Initiatives

National Committee for Quality Assurance - NCQA

Improving Health Data Collection and Standardization in Health Equity and SDoH

Author:

Timshel Tarbet

Director Innovation Health Equity Accelerator

Providence Health Plan

Author:

Abdou Bah

Senior Vice President, Medical Management & Chief Health Equity Officer

Emblem Health

Understanding the Financial Implications of Health Equity and SDoH for Payers and Ensuring ROI

Author:

Lisa Porter

Director of Community Engagement Health Equity & Social Impact

Humana

Author:

Nathaniel Smith

Founder and Chief Equity Officer

Partnership Southern Equity

Such a strong collaboration between sponsors, CROs, Government, Academia, and patient advocates was on display with a shared passion in taking the required actions to solve for patient diversity, equity, and inclusion (DEI). What was affirmed for me is that Workplace Diversity and Patient Diversity are inextricably linked in achieving DEI

Karnel R Walker, Executive Alliance Director, Biopharma Partnerships, Clinical Research Group, Thermo Fisher Scientific

The event demonstrated what a small group of people dedicated to health equity can do to drive engagement in the important discussion about diversity in clinical trials

Molly Madziva, Sr. Director, Global Clinical Affairs, Viz.Ai

A great opportunity to connect with leaders across the healthcare industry who are doing necessary work to help close the health equity gap. It was helpful, reaffirming, and inspiring to better understand the perspectives and actionable strategies different organizations are taking.

Matthew Howard, Senior Director and DEI Lead, Vynamic

The inaugural Health Equity Congress brought colleagues from across the industry together for the first time. It was wonderful to hear successes, best practices and how we could all continue to work together.

LaShell Robinson, Senior Director of Diversity, Equity & Inclusion in Clinical Research, Takeda

This event provided me an opportunity to speak with health equity leaders that I would not have had a chance to meet at larger conferences. I appreciated that although the conference was solely focused on Health Equity, that there was still broad diversity across topics. Really enjoyed my time!

Nader Daoud, Sr. Manager, Clinical Trial Diversity & Inclusion, Moderna

It was so energizing being amongst the health equity thought and practice leaders from across the globe!

Leigh Boehmer, Oncology Clinical Pharmacy Specialist, Association of Community Cancer Centers

Rarely have I witnessed an ENTIRE congress dedicated to DEI initiatives, impact, and future perspectives. Historically having a session focused on DEI was either non-existent or crammed at the end when most attendees would be shuffling to airport to get home. Therefore, I highly recommend this congress not only for learning but for reaffirming one’s mission towards health equity for all.

Denise Bronner, Ph.D., Director, Diversity & Inclusion in Clinical Trials, Janssen

Without a doubt, one of the best conferences I've ever attended. Speakers were all excellent; shared real examples of what they're doing to make a difference. Audience was highly engaged.

Cathleen Peipher, Senior Manager, Global Medical Affairs, Incyte

OUR SELECTION COMITTEE

Author:

Brannon Morisoli

Director

SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr. Morisoli began his career at Neurografix, a startup medical technology company in Santa Monica, CA that was doing groundbreaking work in the MRI imaging of peripheral nerves. While with Neurografix, he was published in two leading neurology journals. Brannon graduated from UCLA with a B.S., was awarded a fellowship and graduated from the University of Notre Dame with an M.B.A, and was awarded a Samson Fellowship from the University of Wisconsin Law School, where he graduated with a J.D. Mr. Morisoli is an inactive member of the State Bar of Wisconsin

Author:

Thomas Busby

Vice President

Outcome Capital

Thomas Busby is a Vice President and has been with Outcome Capital since 2015. He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches. Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Author:

Robert Crousore

Managing Partner

Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

Has successfully managed a global commercial organization in the wound care business.
Has a number of patent credits for products in the wound care industry.
Sits on multiple boards of healthcare technology companies.
His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.

Author:

Brannon Morisoli

Director

SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr. Morisoli began his career at Neurografix, a startup medical technology company in Santa Monica, CA that was doing groundbreaking work in the MRI imaging of peripheral nerves. While with Neurografix, he was published in two leading neurology journals. Brannon graduated from UCLA with a B.S., was awarded a fellowship and graduated from the University of Notre Dame with an M.B.A, and was awarded a Samson Fellowship from the University of Wisconsin Law School, where he graduated with a J.D. Mr. Morisoli is an inactive member of the State Bar of Wisconsin

Author:

Thomas Busby

Vice President

Outcome Capital

Thomas Busby is a Vice President and has been with Outcome Capital since 2015. He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches. Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Author:

Robert Crousore

Managing Partner

Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

Has successfully managed a global commercial organization in the wound care business.
Has a number of patent credits for products in the wound care industry.
Sits on multiple boards of healthcare technology companies.
His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.

REGISTER YOUR INTEREST

Join the health equity community of pharmaceutical clin ops leaders, payers, and healthcare providers to unite and tackle healthcare inequities at every patient touchpoint. Be part of the change that ensures equitable access and quality care for all.

Why attend?

Drive community health initiatives to ensure preventative health with long lasting SDoH strategies and partnerships
Create data driven population health approaches to improve patient stratification
Ensure efficient health equity & SDoH functions through case studies from payers and providers

Jump to: Day 1 | Day 2

Printable version

Wednesday, 8 May, 2024

9:05am

The Importance of Health Equity and Social Determinants of Health (SDoH) in Payer Strategies.

Discover how health equity and SDoH have the potential to improve the financial situation for payers and reduce the financial burden on the health system through promoting preventative care, reducing emergency department visits and enhancing overall population health and ensure your compliance of the joint commissions accreditation standard.

Author:

Roslyn Moore

Deputy Director for Programs

Office of Minority Health

9:30am

Understanding the Financial Implications of Health Equity and SDoH for Payers and Ensuring ROI

Explore the financial impact of social determinants on healthcare costs and population health outcomes. Understand the role of payers in promoting the focus on health equity and the need of collaboration to implement the new strategies.

Author:

Lisa Porter

Director of Community Engagement Health Equity & Social Impact

Humana

Author:

Robyn Bussey

Director, Just Health

Partnership for Southern Equity

Thursday, 9 May, 2024

9:45 am

Improving Health Data Collection and Standardization in Health Equity and SDoH.

Uncover how we can move towards a standardisation of health data collection and use across states. Understanding how leaders utilise and collect health information, how we can Improve systems and data capture from a state community and zip code level.

Author:

Timshel Tarbet

Director Innovation Health Equity Accelerator

Providence Health Plan

Author:

Abdou Bah

Senior Vice President, Medical Management & Chief Health Equity Officer

Emblem Health

Jump to: Day 1 | Day 2

DOWNLOAD THE AGENDA

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us